CF
LEGN icon

CNA Financial’s Legend Biotech LEGN Stock Holding History

CNA Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,715
Closed -$274K – 121
2022
Q3 		$274K Buy
6,715
+300
+5% +$14.1K 0.1% 145
2022
Q2 		$353K Sell
6,415
-3,640
-36% -$154K 0.12% 150
2022
Q1 		$365K Sell
10,055
-290
-3% -$11.5K 0.11% 165
2021
Q4 		$482K Sell
10,345
-820
-7% -$41.6K 0.13% 161
2021
Q3 		$565K Buy
11,165
+500
+5% +$20.8K 0.15% 153
2021
Q2 		$438K Sell
10,665
-1,867
-15% -$63.5K 0.12% 172
2021
Q1 		$364K Buy
12,532
+5,160
+70% +$141K 0.11% 181
2020
Q4 		$208K Sell
7,372
-610
-8% -$17.6K 0.07% 189
2020
Q3 		$246K Buy
7,982
+1,920
+32% +$64.6K 0.09% 176
2020
Q2 		$258K Buy
+6,062
New +$237K 0.1% 167

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

CNA Financial's LEGN Position: Q4 2022 in Review

CNA Financial sold out of Legend Biotech (LEGN) in Q4 2022, closing a stake of 6,715 shares — an estimated $274K sold.

CNA Financial first reported a position in LEGN in Q2 2020 and held it in 10 quarters. The position peaked at $565K in Q3 2021. 170 funds tracked by Wall St. Rank hold LEGN as of Q4 2022.

  • CNA Financial reported no remaining Legend Biotech position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 6,715 Legend Biotech shares in Q4 2022, an estimated $274K.
  • CNA Financial first reported a position in Legend Biotech in Q2 2020 and held it in 10 quarters.
  • CNA Financial's Legend Biotech position peaked at $565K in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.